Bellezzo Murillo, Fonseca Gabriel P, Voncken Robert, Verrijssen An-Sofie, Van Beveren Celine, Roelofs Erik, Yoriyaz Hélio, Reniers Brigitte, Van Limbergen Evert J, Berbée Maaike, Verhaegen Frank
Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands; Centro de Engenharia Nuclear, Instituto de Pesquisas Energéticas e Nucleares IPEN-CNEN/SP, São Paulo, Brazil.
Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
Brachytherapy. 2020 Jul-Aug;19(4):544-553. doi: 10.1016/j.brachy.2020.03.009. Epub 2020 May 6.
Dose escalation yields higher complete response to rectal tumors, which may enable the omission of surgery. Dose escalation using 50 kVp contact x-ray brachytherapy (CXB) allow the treatment of a selective volume, resulting in low toxicity and organs-at-risk preservation. However, the use of CXB devices is limited because of its high cost and lack of treatment planning tools. Hence, the MAASTRO applicator (for HDR Ir sources) was developed and characterized by measurements and Monte Carlo simulations to be a cost-effective alternative to CXB devices.
A cylindrical applicator with lateral shielding was designed to be used with a rectoscope using its tip as treatment surface. Both the applicator and the rectoscope have a slanted edge to potentially allow easier placement against tumors. The applicator design was achieved by Monte Carlo modeling and validated experimentally with film dosimetry, using the Papillon 50 (P50) device as reference.
The applicator delivers CXB doses in less than 9 min using a 20375 U source for a treatment area of approximately 20 × 20 mm at 2 mm depth. Normalized at 2 mm, the dose falloff for depths of 0 mm, 5 mm, and 10 mm are 130%, 70%, and 43% for the P50 and 140%, 67%, and 38% for the MAASTRO applicator, respectively.
The MAASTRO applicator was designed to use HDR Ir sources to deliver a dose distribution similar to those of CXB devices. The applicator may provide a cost-effective solution for endoluminal boosting with clinical treatment planning system integration.
剂量递增可提高直肠肿瘤的完全缓解率,这可能使手术得以省略。使用50 kVp接触式X射线近距离放射疗法(CXB)进行剂量递增能够治疗特定体积,从而降低毒性并保护危及器官。然而,由于CXB设备成本高昂且缺乏治疗计划工具,其应用受到限制。因此,开发了MAASTRO施源器(用于高剂量率铱源),并通过测量和蒙特卡罗模拟进行表征,以成为CXB设备具有成本效益的替代方案。
设计了一种带有侧向屏蔽的圆柱形施源器,使其与直肠镜配合使用,以直肠镜尖端作为治疗表面。施源器和直肠镜都有倾斜边缘,可能便于更轻松地贴合肿瘤放置。施源器设计通过蒙特卡罗建模实现,并使用Papillon 50(P50)设备作为参考,通过胶片剂量测定法进行实验验证。
使用20375 U源时,施源器在不到9分钟内即可为深度2 mm处约20×20 mm的治疗区域提供CXB剂量。在2 mm处归一化后,P50在0 mm、5 mm和10 mm深度处的剂量衰减分别为130%、70%和43%,而MAASTRO施源器分别为140%、67%和38%。
MAASTRO施源器设计用于使用高剂量率铱源提供与CXB设备相似的剂量分布。该施源器通过集成临床治疗计划系统,可能为腔内增强提供具有成本效益的解决方案。